Lupus Capital PLC
19 October 2001
FOR IMMEDIATE RELEASE 19 October 2001
LUPUS CAPITAL PLC ('Lupus' or the 'Company')
Directors Shareholding
Lupus announces that, pursuant to election by the three non-executive
directors of Lupus to receive fifty per cent. of their entitlement to
directors' fees in the form of shares, ordinary 0.5p shares in Lupus
('Ordinary Shares') were allotted today in relation to the six month period
ended 30 September 2001 as follows:
Ordinary Shares In lieu of fee
£
Oliver Stocken 103,093 5,000
Peter Cawdron 77,320 3,750
Peter So 77,320 3,750
The shares were issued at a price of 4.85p, being the average of the closing
mid-market prices of Ordinary Shares for the five trading days to 28 September
2001.
Application to the UK Listing Authority and to the London Stock Exchange for
the above shares to be listed and admitted to trading respectively will be
made in due course.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.